Controversy exists whether vascular smooth muscle cells in vivo synthesize renin, thereby providing a critical component of the hypothesized vascular renin-angiotensin system. To examine this question, we enzymatically isolated and pooled the medial layer of thoracic aortas from Sprague-Dawley rats that were either untreated or enalapril treated for 3 days, isolated messenger RNA (mRNA), and performed Northern blot analysis with rat complementary DNA (cDNA) probes for renin, cathepsin D, and cathepsin E. Renin mRNA was detected in kidney but was not detected in aortic smooth muscle from the untreated or enalapril-treated groups. Cathepsin E mRNA was detected in enalapril-treated aorta and kidney, and cathepsin D mRNA was detected in all tissues examined. cDNA was synthesized and subjected to polymerase chain reaction analysis by using primers corresponding in sequence to regions conserved throughout the aspartic proteinases. Cathepsins D and E were amplified from kidney and aortic cDNA. Renin was less consistently amplified from the aortic cDNA and was much less abundant than cathepsin E or cathepsin D. These results suggest that 1) renin mRNA is present in aortic smooth muscle cells in vivo in quantities detectable only after multiple rounds of polymerase chain reaction amplification, 2) renin mRNA is not upregulated in aortic smooth muscle after converting enzyme inhibition, and 3) cathepsins D and E are the predominant aspartic proteinases in aortic smooth muscle. 4 and in whole aortic mRNA isolated from Wistar-Kyoto rats by using nuclease protection techniques. 5 In contrast to these studies, tissue reninlike activity was not detected in rat aortas isolated from nephrectomized rats, 6 suggesting that vascular-derived renin is of renal origin. Also, Ekker et al, 7 using renin-specific primers for polymerase chain reaction (PCR) analysis, were unable to amplify renin from RNA isolated from various tissues, all of From the Department of Pharmacology (B
T he existence of a vascular renin-angiotensin system was first hypothesized in 1964 by Gould et al 1 after finding the presence of reninlike enzymatic activity in blood vessels. To support the hypothesis that renin is derived from the vasculature, Re et al 2 detected the synthesis of renin by cultured canine aortic smooth muscle cells with immunocytochemical staining and incorporation of radiolabeled amino acids into protein immunoprecipitated with a renin antibody. Renin messenger RNA (mRNA) has been detected in the vasculature of the renal cortex of neonatal rats and sheep by using in situ hybridization 3 -4 and in whole aortic mRNA isolated from Wistar-Kyoto rats by using nuclease protection techniques. 5 In contrast to these studies, tissue reninlike activity was not detected in rat aortas isolated from nephrectomized rats, 6 suggesting that vascular-derived renin is of renal origin. Also, Ekker et al, 7 using renin-specific primers for polymerase chain reaction (PCR) analysis, were unable to amplify renin from RNA isolated from various tissues, all of which retained their full complement of blood vessels when RNA was harvested.
Although these studies represent conflicting results, they do suggest that blood vessels and cultured smooth muscle cells can express renin under certain conditions. However, none of these studies specifically investigated the expression of the renin gene in the smooth muscle layer of freshly isolated large vessels, such as the aorta, where local production of angiotensin II (Ang II) may contribute to the significant changes in smooth muscle cell phenotype that occur in hypertension and atherosclerotic disease. Therefore, the goals of the experiments described in this article were to determine 1) whether the medial (smooth muscle) layer of the rat aorta expresses the renin gene and 2) whether this expression is enhanced by inhibiting converting enzyme with enalapril, a treatment that has been shown to enhance expression of renal renin mRNA. 8 - 9 The presence of renin mRNA was determined by both Northern blot and PCR analysis. The sequences of the primers used for the PCR were selected for conserved aspartic residues found among the aspartic proteinases. Therefore, the presence of cathepsin D and cathepsin E transcripts could also be determined and compared with the expression of renin.
Methods
Male Sprague-Dawley rats (250-350 g) were decapitated, and the medial layers of the thoracic aortas were isolated as described previously. 10 collected from one of the groups (n=24). Another group of rats (n=20) was treated with enalapril (0.2 mg/ml) in drinking water for 3 days. This dose of enalapril has been shown to increase the steady-state level of renin mRNA in rat kidneys. 11 Also, kidneys were collected from nontreated and enalapril-treated rats. Total RNA was isolated by the method of Chirgwin et al. 12 Poly(A) + mRNA was isolated by oligo(dT)-cellulose chromatography. Recovery of poly(A) + RNA was 2-5% of total RNA. Poly(A) + RNA (2 fig) or total RNA (20 fig) was subjected to Northern analysis as described previously. 11 Northern blots were then rinsed in l x SSPE at 100°C for 15 minutes and then rehybridized with another phosphorus-32-labeled complementary DNA (cDNA). Double-stranded cDNA was synthesized from 2-5 /ig poly(A) + mRNA by using the cDNA Synthesis System Plus Kit (Amersham Corp., Arlington Heights, 111.). Two oligonucleotides (5'-TTT-GAC-ACG-GGT-TCC-TCC-AAC-CTC/G-TGG-3' and 5'-CAT-GCC-CAG-AAT-CCC-ATC-AAA-3') were synthesized on a Biosearch 8600 synthesizer, purified by high-performance liquid chromatography, and used to amplify by PCR a 282-bp fragment of the rat renin gene located between nucleotides 334 and 615. 13 These PCR primers are capable of amplifying cathepsin D (303 bp between nucleotides 341 and 644 14 ) and cathepsin E (282 bp of a rat sequence obtained by J.K. Harrison, unpublished data) in addition to renin. Two oligonucleotides (5'-AGC-AAG-CTT-CTC-GAG-GAG-GAC-3' and 5'-GTC-AGC-TGC-AGC-CTT-GGC-GGC-CCT-3')were synthesized to amplify the smooth muscle-specific exon 2 (144 bp) of a-tropomyosin. 15 Also, two oligonucleotides (5' -A AG-CTA-ACT-GAG-ATC-ATC-A AC-A-3' and S'-ATG-CGA-AAG-TTG-GGT-GTC-TGC-A-S') were synthesized to amplify by the PCR a 418-bp fragment of glyceraldehyde-3-phosphate dehydrogenase (GPD). GPD and a-tropomyosin were used to confirm that RNA obtained from the aorta and kidney was relatively intact and sufficiently reverse transcribed. DNA fragments were amplified by the PCR in a total volume of 50 fi\ containing 30 ng double-stranded cDNA and subjected to 35 cycles of 94°C (1 minute), 55°C (2 minutes), and 72°C (3 minutes) on a Temp Cycler (Coy Laboratory Products Inc., Ann Arbor, Mich.).
Southern Blot Analysis
DNA fragments from the PCR were subjected to electrophoresis on 1.4% agarose gels made with l x Tris-borate-EDTA buffer and 1 /u.g/ml ethidium bromide. Ethidium-stained gels were visualized and photographed on an ultraviolet light box, denatured, neutralized, rinsed, and then transferred to nylon (MSI Corp.) by capillary action. The blots were ultraviolet fixed, baked, prehybridized in 5x SSPE, 0.2% sodium dodecyl sulfate, 10x Denhardts, 0.05% NaPP,, and 100 fig/ml salmon sperm DNA at 65°C for 1 hour and then hybridized with phosphorus-32-labeled probes for 48 hours. Blots were washed two times for 15 minutes at room temperature in 2x SSPE and 0.05% NaPP,, two times for 15 minutes at room temperature in 0.2 x SSPE, 0.05% NaPP,, and 0.05% sodium dodecyl sulfate and then two times for 10 minutes at 65°C in 0.2 x SSPE, 0.05% NaPP,, and 0.05% sodium dodecyl sulfate. Blots were rinsed in 10 mM phosphate buffer, dried, and subjected to autoradiography.
Hybridization Probes
Full-length rat renin cDNA was a gift from K. Lynch (University of Virginia, Charlottesville). Full-length rat cathepsin D (1.9 kb) was isolated from a rat brain stem cDNA library. A 750-bp fragment of cDNA encoding most of the coding region of the rat analogue of cathepsin E was amplified from rat brain cDNA by using the PCR. Exon 2 of a-tropomyosin was derived by the PCR from a probe containing exons 1, 2, and 4 obtained from B. Nadal-Ginard (Harvard Medical School, Boston, Mass.). Full-length cDNA for GPD was Results Northern analysis for aspartic proteinases detected renin mRNA in both kidney samples, with greater levels detected in the enalapril-treated kidney (Figure 1 ). Northern analysis did not reveal renin mRNA in aortic smooth muscle (nontreated or enalapril treated), adventitia, or cultured smooth muscle cells. Cathepsin E mRNA was detected in enalapril-treated aorta and nontreated and enalapril-treated kidney. Kidney samples contained three different-sized transcripts for cathepsin E, consistent with the presence of multiple transcripts identified in a human adenocarcinoma cell line. 16 Cathepsin D mRNA was detected in all tissues examined.
PCR amplification with aspartic proteinase-selective primers was then performed in an effort to enhance the possibility of detection of renin mRNA in aortic samples. An equal quantity of starting material (30 ng cDNA) was used in each PCR, and an equal volume of the final reaction product was subjected to electrophoresis, resulting in the ethidium bromide-stained gel shown in Figure 2A . Aliquots of the PCR performed with cDNA from either nontreated or enalapril-treated kidney samples demonstrated prominent ethidium bromide-stained bands of similar size as that obtained when either full-or partial-length cDNAs encoding renin, cathepsin D, or cathepsin E were used as a template. PCR products of the appropriate size were faintly detectable from reactions containing cDNA from nontreated aorta (both samples), but when cDNA from enalapril-treated aorta or adventitia was used, no visible ethidium bromide-stained PCR products were obtained. Southern blots of three identical gels probed with renin, cathepsin E, and cathepsin D demonstrated that renin was more prominent in renal samples than in aortic samples (lanes 1 and 3 showed very faint hybridization to renin cDNA) ( Figure 2B ). The minimal levels of renin in the aorta detected by the PCR were not enhanced by enalapril treatment. Hybridization with phosphorus-32-labeled cathepsin E cDNA revealed bands of nearly equal autoradiographic intensity in both aortic samples and renal samples. Cathepsin D cDNA hybridization was greater in aortic samples than in renal samples. The cDNA probes hybridized selectively to their respective PCR products and did not demonstrate nonspecific hybridization to the other aspartic proteinases (lanes 7, 8, and 9). A comparison of the intensity of the autoradiographic signal (panel B) to the quantity of DNA visualized by ethidium bromide staining (panel A) suggests that cathepsin E and cathepsin D are more prominent in the aorta than in the kidney.
The integrity of RNA isolation and cDNA synthesis was tested by using the PCR to amplify GPD and a smooth muscle-specific gene, smooth muscle a-tropomyosin (SM-aTM), the mRNAs of which are approximately the same size or larger than the mRNA of renin (renin mRNA, 1.6 kb; SM-aTM mRNA, 1.8 kb; GPD mRNA, 3.5 kb). SM-aTM-and GPD-selective cDNA probes hybridized to PCR products of all tissues examined with the exception of GPD in adventitia (Figure 3 ).
Discussion
The results of experiments described in this article suggest 1) renin mRNA as detected by either Northern analysis or the PCR is present in aortic smooth muscle cells in vivo only in minute quantities, 2) the expression of renin mRNA is not enhanced in aortic smooth muscle after converting enzyme inhibition, and 3) cathepsins D and E are the predominant aspartic proteinases in aortic smooth muscle.
Considering that rat aortas were collected and pooled on two separate occasions (n=40 and n=24) and that the very sensitive PCR technique detected only minimal amounts of renin mRNA from these pooled aortic medial layers, this study suggests that it is vascularassociated renin (of renal origin) and not renin produced locally that contributes to the vascular reninangiotensin system. This is consistent with the findings that renin antibodies, converting enzyme inhibitors, and Ang II receptor antagonists do not alter blood pressure in 48-hour bilaterally nephrectomized rats 17 and that there is no reninlike activity obtained from the aorta and microvessels of nephrectomized rats. 6 Although these studies suggest a lack of renin production by aortic smooth muscle cells, they do not preclude the possible production of renin mRNA by resistance vessel smooth muscle cells, by other vascular components such as endothelial cells, 18 or by other strains of rat. 5 Modulation of smooth muscle cell phenotype such as that seen during vascular development 3 ' 4 or in pathological states such as hypertension or vascular injury may induce the expression of renin by smooth muscle cells, and further studies are necessary to examine these possibilities. These studies demonstrate that enalapril treatment does not increase renin mRNA levels in the aorta. This suggests that any locally produced renin is not regulated at the level of gene expression by an Ang II negativefeedback loop in an analagous manner to that observed in the kidney. 8 ' 9 However, Northern analysis suggests there may be an upregulation of cathepsin E and cathepsin D mRNA expression in the aorta after blockade of the renin-angiotensin system. Further investigation in this area is warranted.
Cathepsin D has been localized immunohistochemicalry to all tissues and blood cells (except erythrocytes), resides in lysosomes, and is capable of generating angiotensins in vitro under certain conditions. 19 Cathepsin E appears to have a much more limited tissue distribution and has been localized to several organs involved in immune system regulation as well as to the brush border of the proximal tubules of the kidneys. 20 Northern and PCR analysis shown above confirmed that cathepsin E mRNA is present in the kidney. This is the first report of cathepsin E mRNA being present in vasculature, and the purpose of its presence there is unknown. It has not been reported whether cathepsin E is capable of converting angiotensinogen to either angiotensin I (Ang I) or Ang II, but several aspartic proteinases other than renin are capable of this conversion, including cathepsin D, pepsin, and angiotensinproducing enzyme I of serum.
19
- 21 Active cathepsin E is present on both the inner cell membrane and in the cytoplasm, 22 is capable of generating biologically active peptides from precursor molecules, 23 and retains its activity at a relatively physiological pH of 6.6-7 in the presence of ATP. 24 These characteristics distinguish cathepsin E from both renin (a secreted enzyme) and cathepsin D (a lysosomal enzyme) and may allow cathepsin E to play a role in Ang I or Ang II production in the vasculature. Future studies are warranted to determine whether cathepsin E protein is present in the vascular wall and whether cathepsin E is capable of generating Ang I or Ang II from angiotensinogen.
